BergaCor Plus
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
BergaCor Plus (XYMOGEN), a food supplement au code-barres 871149007294, is described by its US market label, recorded on 14 December 2023. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 14 December 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149007294
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Croscarmellose Sodium, Microcrystalline Cellulose, Ascorbyl Palmitate, Silica, Hydroxypropyl Methylcellulose, Medium Chain Triglyceride
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Bergamot extract (Citrus bergamia) | Plant | 800 mg |
| Amla Extract (Phyllanthus emblica) | Plant | 500 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: BergaCor Plus
Entered into DSLD on 18 July 2023. En vente sur le marché américain (selon le DSLD).Same active composition.
Official label: BergaCor Plus
Entered into DSLD on 26 December 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).Same active composition.
Official label: BergaCor Plus
Entered into DSLD on 26 December 2020. Retirée du marché américain le 31 March 2020 (selon le DSLD).- Same quantity, different name: Capros Amla extract in this version; Amla Extract on the displayed label (500 mg)
- Same quantity, different name: BPF Bergamot extract in this version; Bergamot extract on the displayed label (800 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN